IP Library Granted Patent US 8,586,551
Granted Patent B2
US 8,586,551 · App. 12/551,056 · Granted Nov 19, 2013

18-membered macrocycles and analogs thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,586,551
App. No.
12/551,056
Granted
Nov 19, 2013
Kind
B2
Abstract

The present invention relates generally to the 18-membered macrocyclic antimicrobial agents called Tiacumicins, specifically, OPT-80 (which is composed almost entirely of the R-Tiacumicin B), pharmaceutical compositions comprising OPT-80, and methods using OPT-80. In particular, this compound is a potent drug for the treatment of bacterial infections, specifically C. difficile infections.

Claims (7)

1. An isolated compound having the formula:

free from other stereoisomers of the compound.

2. A pharmaceutical composition comprising the compound of claim 1 or pharmaceutically acceptable salt thereof.

3. The pharmaceutical composition of claim 2 , further comprising one or more pharmaceutically acceptable carriers.

4. The pharmaceutical composition of claim 3 , wherein the composition is formulated for oral administration.

5. The pharmaceutical composition of claim 4 , wherein the composition is formulated as a tablet.

6. A pharmaceutical composition consisting of the compound of claim 1 or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable carriers.

Assignments (5)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 14, 2015
From: OPTIMER PHARMACEUTICALS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036328/0122 →
CHANGE OF NAME Recorded Aug 12, 2015
From: OPTIMER PHARMACEUTICALS, INC.
To: OPTIMER PHARMACEUTICALS LLC
Reel/Frame 036333/0793 →
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: TRIUS THERAPEUTICS, INC.; OPTIMER PHARMACEUTICALS, INC.
Reel/Frame 036178/0175 →
SECURITY AGREEMENT Recorded Nov 13, 2013
From: OPTIMER PHARMACEUTICALS, INC.; TRIUS THERAPEUTICS INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 031628/0850 →